Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

ProstateCancer.me Launched to Address Issues Identified in the First Prostate Cancer Patient Survey


News provided by

Astellas Pharma Inc.

02 Oct, 2019, 10:02 GMT

Share this article

Share toX

Share this article

Share toX

 - Prostatecancer.me, the region's first dedicated platform is launched to inform, educate and address patients' needs   

 - Results from Egypt's first prostate cancer patient survey announced  

 - Only 7% of Egypt's men feel well informed on the disease vs 77% in Europe[1]    

CAIRO, Oct. 2, 2019 /PRNewswire/ -- Advocacy League, CanSurvive, Egyptian Urology Association and Astellas Pharma Inc. today proudly announced the results and insights gained from 'Every Voice Matters' market research conducted with prostate cancer patients and the launch of ProstateCancer.me – first prostate cancer awareness portal in Arabic language, that is addressing some of the identified patients' needs from the research.     

To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/8617451-prostate-cancer-me-launched/   

Continue Reading
This image opens in the lightbox
EveryVoiceMatters Results and ProstateCancer.me launch

"We are very proud to launch ProstateCancer.me, the first patient centric prostate cancer awareness website in our local Arabic language. We hope that having access to information about prostate cancer, disease treatment options, possible lifestyle modifications, as well as advice for the carers will have a positive impact on the patients and their families" said Prof. Mohsen Mokhtar, Founder of Advocacy League.   

Access to information about prostate cancer in local language is necessary for several reasons. Prostate cancer prevalence is estimated to continue to increase across the region[2]. It is estimated that by 2030 prostate cancer incidence will increase by 128% in Saudi Arabia and Lebanon will experience the most modest (38%) incidence increase in the region [2] .

Most men with prostate cancer will not experience any symptoms in early disease stages[3] , hence being aware of the disease symptoms and risk factors, could encourage men to be more proactive in managing their health. According to the results of Every Voice Matters survey with Egyptian prostate cancer patients, 78% of participants have visited their doctor because they were experiencing symptoms vs 32% in Europe[1]. This is highly concerning, as cancer that is detected early is much easier to treat[4].  

Currently prostate cancer patients and their families have very limited amount of information about the prostate cancer, only 7% of survey participants stated that they feel well informed about the disease (vs 77% in Europe)[1]. Prostate Cancer patient Mr. Maan Tawachi shared his story of fighting prostate cancer and reflected on the importance of having access to information "Having the necessary information at my disposal was immensely helpful as I was able to understand how to better manage disease symptoms and treatment side effects. It empowered me to be more involved in the disease management discussions with different doctors who were involved throughout my treatment."

ProstateCancer.me portal provides information about the regional prevalence of prostate cancer, disease symptoms and risk factors, methods for disease detection and diagnosis, healthcare team involved in prostate cancer treatment and their responsibilities, disease staging and available treatment options, suggestions of questions to ask the treating doctor, tips for lifestyle management (diet and exercise) and information specifically for the family and/ or the caregiver.

"We have worked with patient organizations across the region to ensure that ProstateCancer.me provides trusted and reliable information to support all prostate cancer patients and their families." Prof. Mohsen Mokhtar, Founder of Advocacy League. The website is endorsed by patient organizations from across the region: CanSurvive (Egypt), Barbara Nassar (Lebanon), Friends of Cancer Patients (United Arab Emirate), National Cancer Control Foundation (Yemen); Al-Sidra Association (Kuwait) and Shifa for Supporting Cancer Patients (Morocco).

Astellas Pharma is the sponsor of both Every Voice Matters and ProstateCancer.me. Amr Seif, General Manager for MENA/SSA commented on the launch of both initiatives: "Patient centricity is at the core of our business. We are proud to sponsor ProstateCancer.me and Every Voice Matters to address the lack of access to information for patients in the Middle East and listen to their specific needs. We are committed in our continued support to patient organizations and medical societies across the region, in order to address the needs of the patients."  

About Every Voice Matters

Every Voice Matters is a MENA wide initiative that aims to give prostate cancer patients a voice, so that their needs are heard and understood. The initiative is sponsored by Astellas Pharma Inc. and endorsed by medical societies and patient organizations from across the region including CanSurvive (Egypt), Egyptian Urology Association, Emirates Urology Society (UAE), Friends of Cancer patients (UAE), Saudi Cancer Foundation (KSA), Saudi Urology Association (KSA), Lebanese Medical Oncology Society, Lebanese Urology Society, and Barbara Nassar (Lebanon). The research was conducted by the independent research agency, IPSOS.

About ProstateCancer.me  

ProstateCancer.me is the first regional prostate cancer portal in Arabic language that provides information about the disease and empowers patients and their family/caregivers with needed information. The website is created and managed by Arab Advocacy league working, who are in partnership with other patient organizations across the MENA region.  For more information please visit, www.prostatecancer.me 

About Astellas

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information, please visit our website at https://www.astellas.com/en and www.astellasmenassa.com.

About Advocacy League  

Advocacy League is a non-profit organization that constitutes of 16 cancer patients' groups and organizations across the MENA region. The organization is committed to fight cancer across the region through advocacy and healthcare policy initiatives and regional collaboration amongst its members.

About CanSurive

CanSurvive is the leading patients' advocacy group in Egypt that has been successfully operating for over 7 years. The primary objective of this non-profit organization is to support, empower and help adult cancer patients. For more information, please visit https://www.facebook.com/CanSurvive/ 

References:

[1] EveryVoiceMatters:Egypt (2019); Market research conducted by IPSOS and sponsored by Astellas. Report available on file.

[2] GLOBOCAN.

[3] NHS, Symptoms: Prostate Cancer, 2018. Available at https://www.nhs.uk/conditions/prostate-cancer/symptoms/#. Last accessed September 2019

[4] ProstateCancerUK, Localized prostate cancer, 2019. Available at https://prostatecanceruk.org/prostate-information/just-diagnosed/localised-prostate-cancer. Last accessed September 2019    

Photo: https://mma.prnewswire.com/media/1004953/EveryVoiceMatters_ProstateCancer.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.